A low voltage activated Ca2+ current found in a subset of human ventricular myocytes.
Xin ZhangYijia LiXiaoying ZhangValentino PiacentinoDavid M HarrisRemus BerrettaKenneth B MarguliesSteven R HouserXiongwen ChenPublished in: Channels (Austin, Tex.) (2021)
Low voltage activated (ICa-LVA) calcium currents including Cav1.3 and T-type calcium current (ICa-T) have not been reported in adult human left ventricular myocytes (HLVMs). We tried to examine their existence and possible correlation with etiology and patient characteristics in a big number of human LVMs isolated from explanted terminally failing (F) hearts, failing hearts with left ventricular assist device (F-LVAD) and nonfailing (NF) human hearts. LVA (ICa-LVA) was determined by subtracting L-type Ca2+ current (ICa-L) recorded with the holding potential of -50 mV from total Ca2+ current recorded with the holding potential of -90 mV or -70 mV. ICa- LVA was further tested with its sensitivity to 100 µM CdCl2 and tetrodotoxin. Three HLVMs (3 of 137 FHLVMs) from 2 (N = 30 hearts) failing human hearts, of which one was idiopathic and the other was due to primary pulmonary hypertension, were found with ICa-LVA. ICa-LVA in one FHLVM was not sensitive to 100 µM CdCl2 while ICa-LVA in another two FHLVMs was not sensitive to tetrodotoxin. It peaked at the voltage of -40~-20 mV and had a time-dependent decay faster than ICa-L but slower than sodium current (INa). ICa-LVA was not found in any HLVMs from NF (75 HLVMs from 17 hearts) or F-LVAD hearts (82 HLVMs from 18 hearts) but a statistically significant correlation could not be established. In conclusion, ICa-LVA was detected in some HLVMs of a small portion of human hearts that happened to be nonischemic failing hearts.
Keyphrases
- endothelial cells
- induced pluripotent stem cells
- left ventricular
- pulmonary hypertension
- pluripotent stem cells
- heart failure
- left ventricular assist device
- signaling pathway
- climate change
- acute myocardial infarction
- machine learning
- lps induced
- coronary artery disease
- mitral valve
- transcatheter aortic valve replacement
- young adults
- cell proliferation
- aortic valve
- hypertrophic cardiomyopathy